Loading…

Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep

After induction of cecal perforation, 20 anesthetized sheep were randomized to be treated, when arterial blood pressure fell below 75 mm Hg, with vasopressin (fixed dose of 0.02 U/minute), norepinephrine (0.5-5 microg/kg/minute titrated to maintain mean arterial pressure between 75 and 85 mm Hg), va...

Full description

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2003-08, Vol.168 (4), p.481-486
Main Authors: Sun, Qinghua, Dimopoulos, George, Nguyen, Duc Nam, Tu, Zizhi, Nagy, Nathalie, Hoang, Anh Dung, Rogiers, Peter, De Backer, Daniel, Vincent, Jean-Louis
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3
cites cdi_FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3
container_end_page 486
container_issue 4
container_start_page 481
container_title American journal of respiratory and critical care medicine
container_volume 168
creator Sun, Qinghua
Dimopoulos, George
Nguyen, Duc Nam
Tu, Zizhi
Nagy, Nathalie
Hoang, Anh Dung
Rogiers, Peter
De Backer, Daniel
Vincent, Jean-Louis
description After induction of cecal perforation, 20 anesthetized sheep were randomized to be treated, when arterial blood pressure fell below 75 mm Hg, with vasopressin (fixed dose of 0.02 U/minute), norepinephrine (0.5-5 microg/kg/minute titrated to maintain mean arterial pressure between 75 and 85 mm Hg), vasopressin + norepinephrine (vasopressin at fixed dose 0.01 U/minute plus norepinephrine titrated as for norepinephrine only group), or no vasopressor (Ringer's lactate [control]). Mean arterial pressure was well maintained in all treatment groups. Superior mesenteric arterial blood flow was significantly lower in the vasopressin + norepinephrine group than in the vasopressin group. Vasopressin alone or combined with norepinephrine limited the increase in blood lactate concentration and ileal PCO2-gap compared with control and norepinephrine groups. Urine output was higher in the vasopressin group than in control and norepinephrine groups. Survival time was longer in the vasopressin (30 +/- 6 hours) and vasopressin + norepinephrine (30 +/- 3 hours) groups than in the norepinephrine group (20 +/- 1 hours, p < 0.05) and in all treatment groups than in the control group (17 +/- 2 hours, p < 0.05). Tissue injury was less severe in the vasopressin and vasopressin + norepinephrine groups than in the others. In this clinically relevant model of septic shock due to peritonitis, vasopressin administration (alone or with norepinephrine) can prolong survival.
doi_str_mv 10.1164/rccm.200205-447OC
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73552444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>389399941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3</originalsourceid><addsrcrecordid>eNpdkF1LwzAUhoMobn78AG-keCF40ZnTJG16I8j8hMEuNsS70KWntrNtatIx_PdmdiAIgSTkOW_OeQi5ADoBiPmt1bqZRJRGVIScJ_PpARmDYP6SJvTQn2nC_EP6PiInzq0phUgCPSYjiJIURCLH5G5mtuGDcRi8Zc50Fp2r2sCvvsRgaTHrG2z7wBTBAru-0sGiNPpzByxKxO6MHBVZ7fB8v5-S5dPjcvoSzubPr9P7WaiZkH2YF7mmBeRcRoznWosUUpFLP0Oa0xXjVCMAj6gsspxKIWCFsaSSe04WsWan5HqI7az52qDrVVM5jXWdtWg2TiVMiIhz7sGrf-DabGzrW1OQprH_lcUeggHS1jhnsVCdrZrMfiugaidW7cSqQaz6FetrLvfBm1WD-V_F3qQHbgagrD7KbWVRuSara4-Dyta7QIil4opLYD8t9IDC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199619536</pqid></control><display><type>article</type><title>Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep</title><source>Freely Accessible Science Journals - May need to register for free articles</source><source>EZB Electronic Journals Library</source><creator>Sun, Qinghua ; Dimopoulos, George ; Nguyen, Duc Nam ; Tu, Zizhi ; Nagy, Nathalie ; Hoang, Anh Dung ; Rogiers, Peter ; De Backer, Daniel ; Vincent, Jean-Louis</creator><creatorcontrib>Sun, Qinghua ; Dimopoulos, George ; Nguyen, Duc Nam ; Tu, Zizhi ; Nagy, Nathalie ; Hoang, Anh Dung ; Rogiers, Peter ; De Backer, Daniel ; Vincent, Jean-Louis</creatorcontrib><description>After induction of cecal perforation, 20 anesthetized sheep were randomized to be treated, when arterial blood pressure fell below 75 mm Hg, with vasopressin (fixed dose of 0.02 U/minute), norepinephrine (0.5-5 microg/kg/minute titrated to maintain mean arterial pressure between 75 and 85 mm Hg), vasopressin + norepinephrine (vasopressin at fixed dose 0.01 U/minute plus norepinephrine titrated as for norepinephrine only group), or no vasopressor (Ringer's lactate [control]). Mean arterial pressure was well maintained in all treatment groups. Superior mesenteric arterial blood flow was significantly lower in the vasopressin + norepinephrine group than in the vasopressin group. Vasopressin alone or combined with norepinephrine limited the increase in blood lactate concentration and ileal PCO2-gap compared with control and norepinephrine groups. Urine output was higher in the vasopressin group than in control and norepinephrine groups. Survival time was longer in the vasopressin (30 +/- 6 hours) and vasopressin + norepinephrine (30 +/- 3 hours) groups than in the norepinephrine group (20 +/- 1 hours, p &lt; 0.05) and in all treatment groups than in the control group (17 +/- 2 hours, p &lt; 0.05). Tissue injury was less severe in the vasopressin and vasopressin + norepinephrine groups than in the others. In this clinically relevant model of septic shock due to peritonitis, vasopressin administration (alone or with norepinephrine) can prolong survival.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.200205-447OC</identifier><identifier>PMID: 12791578</identifier><language>eng</language><publisher>United States: Am Thoracic Soc</publisher><subject>Animals ; Blood Pressure - drug effects ; Carbon Dioxide - blood ; Cecum - injuries ; Ileum - blood supply ; Intestinal Perforation - complications ; Isotonic Solutions ; Lactates - blood ; Mesenteric Arteries - drug effects ; Norepinephrine - administration &amp; dosage ; Norepinephrine - therapeutic use ; Proportional Hazards Models ; Random Allocation ; Sheep ; Shock, Septic - drug therapy ; Shock, Septic - urine ; Splanchnic Circulation - drug effects ; Statistics, Nonparametric ; Survival Rate ; Vasoconstrictor Agents - administration &amp; dosage ; Vasoconstrictor Agents - therapeutic use ; Vasopressins - administration &amp; dosage ; Vasopressins - therapeutic use</subject><ispartof>American journal of respiratory and critical care medicine, 2003-08, Vol.168 (4), p.481-486</ispartof><rights>Copyright American Thoracic Society Aug 15, 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3</citedby><cites>FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12791578$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Qinghua</creatorcontrib><creatorcontrib>Dimopoulos, George</creatorcontrib><creatorcontrib>Nguyen, Duc Nam</creatorcontrib><creatorcontrib>Tu, Zizhi</creatorcontrib><creatorcontrib>Nagy, Nathalie</creatorcontrib><creatorcontrib>Hoang, Anh Dung</creatorcontrib><creatorcontrib>Rogiers, Peter</creatorcontrib><creatorcontrib>De Backer, Daniel</creatorcontrib><creatorcontrib>Vincent, Jean-Louis</creatorcontrib><title>Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>After induction of cecal perforation, 20 anesthetized sheep were randomized to be treated, when arterial blood pressure fell below 75 mm Hg, with vasopressin (fixed dose of 0.02 U/minute), norepinephrine (0.5-5 microg/kg/minute titrated to maintain mean arterial pressure between 75 and 85 mm Hg), vasopressin + norepinephrine (vasopressin at fixed dose 0.01 U/minute plus norepinephrine titrated as for norepinephrine only group), or no vasopressor (Ringer's lactate [control]). Mean arterial pressure was well maintained in all treatment groups. Superior mesenteric arterial blood flow was significantly lower in the vasopressin + norepinephrine group than in the vasopressin group. Vasopressin alone or combined with norepinephrine limited the increase in blood lactate concentration and ileal PCO2-gap compared with control and norepinephrine groups. Urine output was higher in the vasopressin group than in control and norepinephrine groups. Survival time was longer in the vasopressin (30 +/- 6 hours) and vasopressin + norepinephrine (30 +/- 3 hours) groups than in the norepinephrine group (20 +/- 1 hours, p &lt; 0.05) and in all treatment groups than in the control group (17 +/- 2 hours, p &lt; 0.05). Tissue injury was less severe in the vasopressin and vasopressin + norepinephrine groups than in the others. In this clinically relevant model of septic shock due to peritonitis, vasopressin administration (alone or with norepinephrine) can prolong survival.</description><subject>Animals</subject><subject>Blood Pressure - drug effects</subject><subject>Carbon Dioxide - blood</subject><subject>Cecum - injuries</subject><subject>Ileum - blood supply</subject><subject>Intestinal Perforation - complications</subject><subject>Isotonic Solutions</subject><subject>Lactates - blood</subject><subject>Mesenteric Arteries - drug effects</subject><subject>Norepinephrine - administration &amp; dosage</subject><subject>Norepinephrine - therapeutic use</subject><subject>Proportional Hazards Models</subject><subject>Random Allocation</subject><subject>Sheep</subject><subject>Shock, Septic - drug therapy</subject><subject>Shock, Septic - urine</subject><subject>Splanchnic Circulation - drug effects</subject><subject>Statistics, Nonparametric</subject><subject>Survival Rate</subject><subject>Vasoconstrictor Agents - administration &amp; dosage</subject><subject>Vasoconstrictor Agents - therapeutic use</subject><subject>Vasopressins - administration &amp; dosage</subject><subject>Vasopressins - therapeutic use</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNpdkF1LwzAUhoMobn78AG-keCF40ZnTJG16I8j8hMEuNsS70KWntrNtatIx_PdmdiAIgSTkOW_OeQi5ADoBiPmt1bqZRJRGVIScJ_PpARmDYP6SJvTQn2nC_EP6PiInzq0phUgCPSYjiJIURCLH5G5mtuGDcRi8Zc50Fp2r2sCvvsRgaTHrG2z7wBTBAru-0sGiNPpzByxKxO6MHBVZ7fB8v5-S5dPjcvoSzubPr9P7WaiZkH2YF7mmBeRcRoznWosUUpFLP0Oa0xXjVCMAj6gsspxKIWCFsaSSe04WsWan5HqI7az52qDrVVM5jXWdtWg2TiVMiIhz7sGrf-DabGzrW1OQprH_lcUeggHS1jhnsVCdrZrMfiugaidW7cSqQaz6FetrLvfBm1WD-V_F3qQHbgagrD7KbWVRuSara4-Dyta7QIil4opLYD8t9IDC</recordid><startdate>20030815</startdate><enddate>20030815</enddate><creator>Sun, Qinghua</creator><creator>Dimopoulos, George</creator><creator>Nguyen, Duc Nam</creator><creator>Tu, Zizhi</creator><creator>Nagy, Nathalie</creator><creator>Hoang, Anh Dung</creator><creator>Rogiers, Peter</creator><creator>De Backer, Daniel</creator><creator>Vincent, Jean-Louis</creator><general>Am Thoracic Soc</general><general>American Thoracic Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20030815</creationdate><title>Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep</title><author>Sun, Qinghua ; Dimopoulos, George ; Nguyen, Duc Nam ; Tu, Zizhi ; Nagy, Nathalie ; Hoang, Anh Dung ; Rogiers, Peter ; De Backer, Daniel ; Vincent, Jean-Louis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Blood Pressure - drug effects</topic><topic>Carbon Dioxide - blood</topic><topic>Cecum - injuries</topic><topic>Ileum - blood supply</topic><topic>Intestinal Perforation - complications</topic><topic>Isotonic Solutions</topic><topic>Lactates - blood</topic><topic>Mesenteric Arteries - drug effects</topic><topic>Norepinephrine - administration &amp; dosage</topic><topic>Norepinephrine - therapeutic use</topic><topic>Proportional Hazards Models</topic><topic>Random Allocation</topic><topic>Sheep</topic><topic>Shock, Septic - drug therapy</topic><topic>Shock, Septic - urine</topic><topic>Splanchnic Circulation - drug effects</topic><topic>Statistics, Nonparametric</topic><topic>Survival Rate</topic><topic>Vasoconstrictor Agents - administration &amp; dosage</topic><topic>Vasoconstrictor Agents - therapeutic use</topic><topic>Vasopressins - administration &amp; dosage</topic><topic>Vasopressins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Qinghua</creatorcontrib><creatorcontrib>Dimopoulos, George</creatorcontrib><creatorcontrib>Nguyen, Duc Nam</creatorcontrib><creatorcontrib>Tu, Zizhi</creatorcontrib><creatorcontrib>Nagy, Nathalie</creatorcontrib><creatorcontrib>Hoang, Anh Dung</creatorcontrib><creatorcontrib>Rogiers, Peter</creatorcontrib><creatorcontrib>De Backer, Daniel</creatorcontrib><creatorcontrib>Vincent, Jean-Louis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Qinghua</au><au>Dimopoulos, George</au><au>Nguyen, Duc Nam</au><au>Tu, Zizhi</au><au>Nagy, Nathalie</au><au>Hoang, Anh Dung</au><au>Rogiers, Peter</au><au>De Backer, Daniel</au><au>Vincent, Jean-Louis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2003-08-15</date><risdate>2003</risdate><volume>168</volume><issue>4</issue><spage>481</spage><epage>486</epage><pages>481-486</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>After induction of cecal perforation, 20 anesthetized sheep were randomized to be treated, when arterial blood pressure fell below 75 mm Hg, with vasopressin (fixed dose of 0.02 U/minute), norepinephrine (0.5-5 microg/kg/minute titrated to maintain mean arterial pressure between 75 and 85 mm Hg), vasopressin + norepinephrine (vasopressin at fixed dose 0.01 U/minute plus norepinephrine titrated as for norepinephrine only group), or no vasopressor (Ringer's lactate [control]). Mean arterial pressure was well maintained in all treatment groups. Superior mesenteric arterial blood flow was significantly lower in the vasopressin + norepinephrine group than in the vasopressin group. Vasopressin alone or combined with norepinephrine limited the increase in blood lactate concentration and ileal PCO2-gap compared with control and norepinephrine groups. Urine output was higher in the vasopressin group than in control and norepinephrine groups. Survival time was longer in the vasopressin (30 +/- 6 hours) and vasopressin + norepinephrine (30 +/- 3 hours) groups than in the norepinephrine group (20 +/- 1 hours, p &lt; 0.05) and in all treatment groups than in the control group (17 +/- 2 hours, p &lt; 0.05). Tissue injury was less severe in the vasopressin and vasopressin + norepinephrine groups than in the others. In this clinically relevant model of septic shock due to peritonitis, vasopressin administration (alone or with norepinephrine) can prolong survival.</abstract><cop>United States</cop><pub>Am Thoracic Soc</pub><pmid>12791578</pmid><doi>10.1164/rccm.200205-447OC</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 2003-08, Vol.168 (4), p.481-486
issn 1073-449X
1535-4970
language eng
recordid cdi_proquest_miscellaneous_73552444
source Freely Accessible Science Journals - May need to register for free articles; EZB Electronic Journals Library
subjects Animals
Blood Pressure - drug effects
Carbon Dioxide - blood
Cecum - injuries
Ileum - blood supply
Intestinal Perforation - complications
Isotonic Solutions
Lactates - blood
Mesenteric Arteries - drug effects
Norepinephrine - administration & dosage
Norepinephrine - therapeutic use
Proportional Hazards Models
Random Allocation
Sheep
Shock, Septic - drug therapy
Shock, Septic - urine
Splanchnic Circulation - drug effects
Statistics, Nonparametric
Survival Rate
Vasoconstrictor Agents - administration & dosage
Vasoconstrictor Agents - therapeutic use
Vasopressins - administration & dosage
Vasopressins - therapeutic use
title Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A38%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low-Dose%20Vasopressin%20in%20the%20Treatment%20of%20Septic%20Shock%20in%20Sheep&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Sun,%20Qinghua&rft.date=2003-08-15&rft.volume=168&rft.issue=4&rft.spage=481&rft.epage=486&rft.pages=481-486&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.200205-447OC&rft_dat=%3Cproquest_cross%3E389399941%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c358t-dfdc0f1d48234dcc59195d81649d0b340ce114208fad08551be680845918f6c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=199619536&rft_id=info:pmid/12791578&rfr_iscdi=true